Health-care companies were more or less flat as traders rotated into the defensive sector ahead of jobs data.
Over-the-counter drugs maker Kenvue, which was spun off by Johnson & Johnson, posted growth in second-quarter earnings and revenue.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
August 06, 2026 17:50 ET (21:50 GMT)






